Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
2018 · Nature Medicine · 971 citations
https://doi.org/10.1038/s41591-018-0078-7
P
Peter Savas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
156
Papers
10.0K
Citations
37
h-index
54
i10-index
Peter Savas is an academic researcher from The Royal Melbourne Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Cancer Genomics and Diagnostics. The author has an h-index of 37, co-authored 133 publications.
ORCID: 0000-0001-5999-428XPapers by this author
worksTissue-resident memory T cells in breast cancer control and immunotherapy responses
2020 · Nature Reviews Clinical Oncology · 318 citations
https://doi.org/10.1038/s41571-020-0333-y
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
2020 · npj Breast Cancer · 198 citations
https://doi.org/10.1038/s41523-020-0156-0
Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
2019 · The Breast · 76 citations
https://doi.org/10.1016/j.breast.2019.10.016
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
2018 · Science Signaling · 73 citations
https://doi.org/10.1126/scisignal.aat9773
Clinical implications of prospective genomic profiling of metastatic breast cancer patients
2020 · Breast Cancer Research · 53 citations
https://doi.org/10.1186/s13058-020-01328-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat